Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

PURPOSE: Two phase 2 studies evaluated the efficacy and tolerability of centanafadine sustained-release (SR) for adults with attention-deficit/hyperactivity disorder (ADHD). PATIENTS AND METHODS: In a phase 2a, flexible-dose, single-blind study, 41 male patients (aged 18‒55 years) with a diagnosis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigal, Sharon B, Wigal, Tim, Hobart, Mary, Madera, Jessica J, Baker, Ross A, Kohegyi, Eva, McKinney, Anthony, Wilens, Timothy E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292254/
https://www.ncbi.nlm.nih.gov/pubmed/32606695
http://dx.doi.org/10.2147/NDT.S242084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292254/
https://www.ncbi.nlm.nih.gov/pubmed/32606695
http://dx.doi.org/10.2147/NDT.S242084

Ejemplares similares